Anavex Life Pre-Treatment Prevented Cognitive Impairment In Animal Model of Alzheimer’s Disease, New Publication Shows

All NewsAugust 20, 2025

Anavex published data showing blarcamesine prevented amyloid-related brain damage in mice, supporting SIGMAR1 as a target for Alzheimer’s prevention.

We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies.

Cookie settings ACCEPT

Manage consent